Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Shares Issued (2016 - 2025)

Historic Shares Issued for Editas Medicine (EDIT) over the last 11 years, with Q3 2025 value amounting to $17.1 million.

  • Editas Medicine's Shares Issued changed N/A to $17.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.0 million, marking a year-over-year increase of 798540.37%. This contributed to the annual value of $590000.0 for FY2024, which is 9949.61% down from last year.
  • Editas Medicine's Shares Issued amounted to $17.1 million in Q3 2025.
  • Over the past 5 years, Editas Medicine's Shares Issued peaked at $249.5 million during Q1 2021, and registered a low of -$11000.0 during Q2 2021.
  • For the 5-year period, Editas Medicine's Shares Issued averaged around $30.3 million, with its median value being $268000.0 (2024).
  • Its Shares Issued has fluctuated over the past 5 years, first crashed by 10000.54% in 2021, then soared by 7849060.4% in 2023.
  • Over the past 5 years, Editas Medicine's Shares Issued (Quarter) stood at $1000.0 in 2021, then soared by 61100.0% to $612000.0 in 2022, then soared by 19033.99% to $117.1 million in 2023, then crashed by 99.77% to $268000.0 in 2024, then soared by 6298.51% to $17.1 million in 2025.
  • Its last three reported values are $17.1 million in Q3 2025, $7.2 million for Q2 2025, and $1.4 million during Q1 2025.